ArticlePituitary2014
Clinical features of sellar and suprasellar meningiomas.
Article in Pituitary, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Collision tumors at the skull base: unveiling a somatotroph pituitary adenoma coexisting with a petroclival meningioma. Illustrative case.Journal of neurosurgery. Case lessons · 2026Article
- Role of diffusion-weighted imaging in the diagnosis of pituitary region tumors.Neuroradiology · 2025Article
- Sellar and perisellar meningiomas: effects on pituitary function in a Spanish cohort observational study.Pituitary · 2024Observational
- Suprasellar Meningioma Classification: Endoscopic Transnasal Perspective.Journal of neurological surgery. Part B, Skull base · 2024Article
- Neuroimaging of hypophysitis: etiologies and imaging mimics.Japanese journal of radiology · 2023Review
- Article
- Article
- Differentiation of suprasellar meningiomas from non-functioning pituitary macroadenomas byBMC cancer · 2020Article
- Cushing's disease due to a pituitary adenoma as a component of collision tumor: A case report and review of the literature.Journal of medical case reports · 2020Article
- Sellar and Parasellar Pain Syndromes.Current pain and headache reports · 2019Review
- 18 beta-glycyrrhetinic acid ameliorates the cognitive functions and decreases the recurrence rate of pituitary adenomas patients.EXCLI journal · 2018Article
- Factors Affecting Visual Field Outcome Post-Surgery in Sellar Region Tumors: Retrospective Study.The Malaysian journal of medical sciences : MJMS · 2017Article
- MR imaging of brain pilocytic astrocytoma: beyond the stereotype of benign astrocytoma.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2017Review
- Expression of cold-inducible RNA-binding protein (CIRP) in pituitary adenoma and its relationships with tumor recurrence.Medical science monitor : international medical journal of experimental and clinical research · 2015Article
- Meningiomas of the tuberculum and diaphragma sellae.Journal of neurological surgery. Part B, Skull base · 2015Article
- Visual loss due to optic chiasm and retrochiasmal visual pathway lesions.Continuum (Minneapolis, Minn.) · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Meningiomas account for about 1% of sellar masses. Although they can mimic pituitary adenomas, they are more vascularized and invasive. To gain insights that would enhance our ability to establish a pre-surgical diagnosis of meningioma, we performed a retrospective study of these tumors. Query of the surgical pathology database identified 1,516 meningiomas operated at out institution between January 2000 and May 2012. Cases were matched to the radiology database to identify a strictly defined sellar and/or suprasellar location. We identified 57 meningiomas. F:M ratio was 6:1. The mean age was 52 years (median 50, range 30-78). The most common symptoms were visual disturbance (58%), headache (16%) and incidental finding (12%). The mean duration of symptoms was 13 months. Hyperprolactinemia was found in 36%, with mean value of 51.6 ng/ml (median 41.8, range 22.5-132). Mean maximal diameter was 2.9 cm (median 2.7, range 0.9-6.8), and most tumors enhanced homogeneously on MRI after gadolinium. A "dural tail" sign was reported in a third. The radiologist reported "likely meningioma" in 65%, "possible meningioma" in 8.7%, and pituitary adenoma in 11%. After surgery, visual disturbances improved in most patients (80%) but headache only in 7%. Post-operative complications at 1 and 3 months occurred 38.6 and 33.3% respectively. There was no mortality. Sellar/suprasellar meningiomas represent 4% of all meningiomas, and have a particularly high female predominance. The diagnosis is suggested by the radiologist in approximately 2/3 of the cases. An improved method to differentiate preoperatively these tumors from adenomas would be desirable.
Indexed as
Identifiers
23975080What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.